These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18781619)

  • 1. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
    Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
    Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.
    Plaschke J; Krüger S; Dietmaier W; Gebert J; Sutter C; Mangold E; Pagenstecher C; Holinski-Feder E; Schulmann K; Möslein G; Rüschoff J; Engel C; Evans G; Schackert HK;
    Hum Mutat; 2004 Mar; 23(3):285. PubMed ID: 14974087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of pathogenicity in human MSH2 missense mutants.
    Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
    Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
    Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
    Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
    Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
    Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
    Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
    Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
    Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome.
    Kariola R; Raevaara TE; Lönnqvist KE; Nyström-Lahti M
    Hum Mol Genet; 2002 May; 11(11):1303-10. PubMed ID: 12019211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
    Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
    Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC.
    Roncari B; Pedroni M; Maffei S; Di Gregorio C; Ponti G; Scarselli A; Losi L; Benatti P; Roncucci L; De Gaetani C; Camellini L; Lucci-Cordisco E; Tricarico R; Genuardi M; Ponz de Leon M
    Clin Genet; 2007 Sep; 72(3):230-7. PubMed ID: 17718861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
    Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
    Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
    Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
    Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
    Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
    Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A database to support the interpretation of human mismatch repair gene variants.
    Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
    Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcoma.
    Hirata K; Kanemitsu S; Nakayama Y; Nagata N; Itoh H; Ohnishi H; Ishikawa H; Furukawa Y;
    Am J Gastroenterol; 2006 Jan; 101(1):193-6. PubMed ID: 16405554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
    Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
    Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.
    Ponti G; Losi L; Pellacani G; Wannesson L; Cesinaro AM; Venesio T; Petti C; Seidenari S
    Br J Dermatol; 2008 Jul; 159(1):162-8. PubMed ID: 18460031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.